Health care-associated infections: Major issues in the early years of the 21st century

Clinical Infectious Diseases

Volumn 45, Issue SUPPL. 1, 2007, Pages

  Wenzel, Richard P ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; IMMUNOGLOBULIN; LINEZOLID; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BIOFILM; CANDIDA; CATHETER; CAUSE OF DEATH; DRUG EFFICACY; HUMAN; MORBIDITY; MORTALITY; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS; REVIEW; STAPHYLOCOCCUS AUREUS; UNITED STATES;

COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; SEPSIS; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 34447124410     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518136     Document Type: Review

References (21)

1. Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerging Infect Dis 2001; 7:174-7.
2. Wenzel RP. Attributable mortality: the promise of better antimicrobial therapy. J Infect Dis 1998; 178:917-9.
3. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-55.
4. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29:239-44.
5. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in US hospitals. Clin Infect Dis 2003; 36:1103-10.
6. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005; 13:34-40.
7. Yao Y, Sturdevant DE, Otto M. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis 2005; 191:289-98.
8. Wu J, Kusuma C, Mond JJ, Kokai-Kun JE Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surface. Antimicrob Agents Chemother 2003; 47:3407-14.
9. Greenberg, EP. Bacterial communication and group behavior. J Clin Invest 2003; 112:1288-90.
10. Hentzer M, Givskov M. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J Clin Invest 2003; 112:1300-7.
11. Bischoff WE, Reynolds TM, Sessler CN, Edmond MB, Wenzel RP. Handwashing compliance by health care workers: the impact of introducing an accessible, alcohol-based hand disinfectant. Arch Intern Med 2000; 160:1017-21.
12. Pittet D. Improving adherence to hand hygiene proactive: a multidisciplinary approach. Emerg Infect Dis 2001; 7:234-40.
13. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative handwashing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992; 327:88-93.
14. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA 300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-9.
15. Saiman L, O'Keefe M, Graham PL 3rd, et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003; 37:1313-9.
16. Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005; 33:385-91.
17. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated bloodstream infections. Clin Infect Dis 2006; 42:647-56.
18. Bernardo K, Pakulat N, Fleer S, et al. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 2004; 48:546-55.
19. Micek ST, Dunne M, Kollef MH. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 2005; 128:2732-8.
20. Wenzel RP, Bearman GM, Edmond MB. Community acquired methicillin- resistant Staphylococcus aureus: new issues for infection control. Internat J Antimicrob Agents [in press].
21. Stevens DL, Wallace RJ, Hamilton SM, Bryant AE. Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro shock syndrome toxin type 1 in the presence of antibiotics. Clin Infect Dis 2006; 42:729-30.